Supplementary Methods from IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer
Tadashi Manabe(Keio University), Kenzo Soejima(Keio University), Toshiki Ebisudani(Keio University), Harumi Kagiwada(National Institute of Advanced Industrial Science and Technology), Keigo Kobayashi(Osaka Gakuin University), Keita Masuzawa(Kitasato Institute Hospital), Shinnosuke Ikemura(Keio University), Katsuhisa Horimoto(National Institute of Advanced Industrial Science and Technology), Hideki Terai(Kitasato Institute Hospital), Koichi Fukunaga(Keio University), Junko Hamamoto(Keio University), Kazuhiko Fukui(National Institute of Advanced Industrial Science and Technology), Hiroyuki Yasuda, Ichiro Kawada(Keio University)
Cited by 0
Related Papers
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
|Nature Medicine|2018|317
<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
|Oncotarget|2015|159
A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker
|npj Digital Medicine|2020|112